Skip to content

Clarivate CLVT IP — Goodwill impairment

Other segment segments

Life Sciences & Healthcare
$149.1M+156%
A&G
$0

Similar metrics at other companies

General Mills logo
GISInternational — Goodwill impairment
$0
Hain Celestial Group logo
HAINInternational — Goodwill Impairment
$193.84M+989%
Telos Corporation logo
TLSImpairment loss on intangible assets — Goodwill impairment
$3.73M
Pacific Biosciences of California logo
PACBGoodwill And Intangible Asset Impairment
$0-100%
WEBTOON Entertainment Inc. logo
WBTNGoodwill And Intangible Asset Impairment
$84.12M+382%
Sylvamo logo
SLVMGoodwill And Intangible Asset Impairment
$2.75M

Other financials

Income statement

See full
Revenue$587.3M-5.5%
Gross profit$401.8M-3.8%
Operating income-$200.2M-3,001%
Net income-$268.6M-273%
EPS (diluted)-$0.42-282%

Balance sheet

See full
Cash & equivalents$217.7M-40.0%
Total debt$4.3B-7.4%
Total equity$4.5B-9.1%
Total assets$10.5B-8.2%

Cash flow

See full
Operating cash flow$98.7M-15.1%
CapEx$54.7M-17.1%
Free cash flow$44.0M-12.5%

Valuation

See full
Market cap$1.36B-46.9%
Enterprise value$5.47B-21.6%
P/S0.6×-0.5×

Profitability

See full
Gross margin66.8%+0.8pp
Operating margin-3.5%+5.5pp
Net margin-14%-2.3pp
FCF margin13.6%-0.3pp

Returns & leverage

See full
Return on equity-7.1%-0.8pp
Debt / equity0.0×
Current ratio0.8×-0.1×

Where this comes from

Reported directly by Clarivate in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: Clarivate’s 10-K, filed February 19, 2025, on SEC EDGAR. View the filing →

Ask your AI about Clarivate's ip — goodwill impairment.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clarivate's IP — goodwill impairment?
Clarivate (CLVT) reported IP — goodwill impairment of $13.8M in Q3 2024.
What does IP — goodwill impairment mean?
This represents a non-cash charge recognized when the carrying value of goodwill associated with the Intellectual Property segment exceeds its implied fair value. It serves as a critical indicator that the expected economic benefits from past acquisitions have declined due to market shifts or underperformance. Frequent or large impairments signal potential issues with historical capital allocation or deteriorating competitive positioning within the IP market.